entity

CKD

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CKD: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
0Hypotheses
0Analyses
1Outgoing
1Incoming

Wiki Pages (20)

Knowledge base pages for this entity

lithium-tauopathy

therapeutic · 4282 words

Beta-Amyloid 42/40 Ratio - Biomarker

biomarker · 3667 words

Protein Biomarkers in Neurodegeneration

mechanism · 3567 words

KarXT+EC Phase 3 (NCT07011732): Enhanced Formulation for AD Agitation

clinical · 3402 words

FGF23 — Fibroblast Growth Factor 23

gene · 3323 words

Outgoing (1)

TargetRelationTypeStr
Cognitive Impairmentcausesphenotype0.95

Incoming (1)

SourceRelationTypeStr
CHIPassociated_withdisease0.70

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found